Public shortage context is available across 18 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
| Drug Name | NDC 11 | Manufacturer | Shortage Context |
|---|
| acetylcysteine 200 mg / mL Injection 30 mL NDC 25021-0812-30 | 4 Vial | Sagent Pharmaceuticals | 25021-0812-30 | Sagent Pharmaceuticals | Current shortage context |
| Acetylcysteine 6 g / 30mL Injection 30 mL NDC 55150-0259-30 | 4 Vial, Single-Dose | Eugia US LLC | 55150-0259-30 | Eugia US LLC | Current shortage context |
| Acetylcysteine 200 mg / mL Injection 30 mL NDC 63323-0963-30 | 4 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0963-30 | Fresenius Kabi USA, LLC | Current shortage context |
| Acetylcysteine 200 mg / mL Injection 30 mL NDC 68462-0946-12 | 4 Vial, Single-Dose | Glenmark Pharmaceuticals Inc., USA | 68462-0946-12 | Glenmark Pharmaceuticals Inc., USA | Current shortage context |
| Acetylcysteine 200 mg / mL Injection 30 mL NDC 70594-0111-02 | 4 Vial | Xellia Pharmaceuticals USA LLC | 70594-0111-02 | Xellia Pharmaceuticals USA LLC | Current shortage context |
| acetylcysteine 100 mg / mL Inhalant 4 mL NDC 00517-7504-25 | 25 Vial, Glass | American Regent, Inc. | 00517-7504-25 | American Regent, Inc. | Historical shortage context |
| acetylcysteine 100 mg / mL Inhalant 10 mL NDC 00517-7510-03 | 3 Vial, Glass | American Regent, Inc. | 00517-7510-03 | American Regent, Inc. | Historical shortage context |
| acetylcysteine 200 mg / mL Inhalant 4 mL NDC 00517-7604-25 | 25 Vial, Glass | American Regent, Inc. | 00517-7604-25 | American Regent, Inc. | Historical shortage context |
| acetylcysteine 200 mg / mL Inhalant 10 mL NDC 00517-7610-03 | 3 Vial, Glass | American Regent, Inc. | 00517-7610-03 | American Regent, Inc. | Historical shortage context |
| Acetylcysteine 200 mg / mL Solution 30 mL NDC 63323-0690-30 | 3 Vial | Fresenius Kabi USA, LLC | 63323-0690-30 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 200 mg / mL Solution 30 mL NDC 63323-0690-44 | 3 Vial | Fresenius Kabi USA, LLC | 63323-0690-44 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 100 mg / mL Solution 30 mL NDC 63323-0691-30 | 3 Vial | Fresenius Kabi USA, LLC | 63323-0691-30 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 200 mg / mL Solution 10 mL NDC 63323-0692-10 | 3 Vial | Fresenius Kabi USA, LLC | 63323-0692-10 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 100 mg / mL Solution 10 mL NDC 63323-0693-10 | 3 Vial | Fresenius Kabi USA, LLC | 63323-0693-10 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 200 mg / mL Solution 4 mL NDC 63323-0694-04 | 25 Vial | Fresenius Kabi USA, LLC | 63323-0694-04 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 100 mg / mL Solution 4 mL NDC 63323-0695-04 | 25 Vial | Fresenius Kabi USA, LLC | 63323-0695-04 | Fresenius Kabi USA, LLC | Historical shortage context |
| Acetylcysteine 100 mg / mL Solution 30 mL NDC 00409-3307-03 | 3 Vial | Hospira, Inc. | 00409-3307-03 | Hospira, Inc. | Historical shortage context |
| Acetylcysteine 200 mg / mL Solution 30 mL NDC 00409-3308-03 | 3 Vial | Hospira, Inc. | 00409-3308-03 | Hospira, Inc. | Historical shortage context |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.